Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration

NCT07174739 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.

NCT NCT07174739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration
Lead sponsor
Singapore Eye Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic corneal pain